Smart home tech could spot early dementia signs

NCT ID NCT06704971

Ongoing Knowledge-focused Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Stanford study is testing whether non-intrusive sensors placed in the home can automatically track neuropsychiatric symptoms like mood changes and agitation in older adults. Researchers will enroll 25 participants with or at risk of mild cognitive impairment or dementia, along with healthy controls. The goal is to create a dashboard for doctors that summarizes symptom patterns, making it easier to diagnose and manage mental health conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: non-intrusive ambient intelligence technologies (in-home video and audio sensors)
What this could lead to: If successful, this could lead to a system that helps doctors monitor mental health symptoms at home, potentially catching early signs of dementia or cognitive decline.
What could go wrong: This is a small, early-stage study with only 25 participants. The technology may not work as expected in real-world homes, and privacy concerns could limit adoption.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction dementia Memory Disorders nail-patella syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEMENTIA DEMENTIA ALZHEIMERS MEMORY IMPAIRMENT MILD COGNITIVE IMPAIRMENT MILD DEMENTIA NPS

Contacts and locations

Locations

Clinical Excellence Research Center

Palo Alto, California, 94304, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.